We do not intend to analyze here the meaning of the title of the article “Could We Address the Interplay Between CD133, Wnt/β-Catenin, and TERT Signaling Pathways as a Potential Target for Glioblastoma Therapy?” by Behrooz and Syahir published recently in Frontiers in Oncology [issue April 1, 2021]. The gene discussed is TERT; the disease is glioblastoma.